ChromaDex Releases New Cannabinoid (CBD) Reference Standards

ChromaDex Corporation, an integrated global nutraceutical company, has added to its reference standards, which are available to researchers around the world. The reference standards are only for laboratory use, and are not for human consumption.

Rob Fried, an executive of the company and a board member of the “Council for Responsible Nutrition” has released a report that the CBD space has an “abundance of misinformation” and a great deal of quality standards testing. He added that the company has supeior standards in testing for “over 20 years” and is looking forward in helping to provide scientific principals for people involved in cannabidiol.

The purpose of reference standards is to provide a benchmark that affirm the identity and effectiveness of merchandise. The company’s catalog has 1,750 phytochemicals and 400 botanical reference materials. Two new reference standards for cannabinoids were added as well.

Frank Jaksch, the co-founder and executive chairman of ChromaDex also shared in the report that the company supports the establishment of “a safe limit” concerning CBD for consumers, and that the company’s ability to aid researchers and merchants to create excellent products that adhere to the claims on product labels.